102 related articles for article (PubMed ID: 31539552)
1. PPARα agonist alleviates tumor growth and chemo-resistance associated with the inhibition of glucose metabolic pathway.
Gou Q; Dong C; Jin J; Liu Q; Lu W; Shi J; Hou Y
Eur J Pharmacol; 2019 Nov; 863():172664. PubMed ID: 31539552
[TBL] [Abstract][Full Text] [Related]
2. PPARα Promotes Cancer Cell Glut1 Transcription Repression.
You M; Jin J; Liu Q; Xu Q; Shi J; Hou Y
J Cell Biochem; 2017 Jun; 118(6):1556-1562. PubMed ID: 27918085
[TBL] [Abstract][Full Text] [Related]
3. Metformin inhibits PPARδ agonist-mediated tumor growth by reducing Glut1 and SLC1A5 expressions of cancer cells.
Ding J; Gou Q; Jin J; Shi J; Liu Q; Hou Y
Eur J Pharmacol; 2019 Aug; 857():172425. PubMed ID: 31150647
[TBL] [Abstract][Full Text] [Related]
4. PPARα ligand, AVE8134, and cyclooxygenase inhibitor therapy synergistically suppress lung cancer growth and metastasis.
Wu L; Wang W; Dai M; Li H; Chen C; Wang D
BMC Cancer; 2019 Dec; 19(1):1166. PubMed ID: 31791289
[TBL] [Abstract][Full Text] [Related]
5. Uncoupling protein-2 up-regulation and enhanced cyanide toxicity are mediated by PPARalpha activation and oxidative stress.
Zhang X; Li L; Prabhakaran K; Zhang L; Leavesley HB; Borowitz JL; Isom GE
Toxicol Appl Pharmacol; 2007 Aug; 223(1):10-9. PubMed ID: 17573087
[TBL] [Abstract][Full Text] [Related]
6. DT-13 inhibited the proliferation of colorectal cancer via glycolytic metabolism and AMPK/mTOR signaling pathway.
Wei X; Mao T; Li S; He J; Hou X; Li H; Zhan M; Yang X; Li R; Xiao J; Yuan S; Sun L
Phytomedicine; 2019 Feb; 54():120-131. PubMed ID: 30668361
[TBL] [Abstract][Full Text] [Related]
7. The truncated splice variant of peroxisome proliferator-activated receptor alpha, PPARα-tr, autonomously regulates proliferative and pro-inflammatory genes.
Thomas M; Bayha C; Klein K; Müller S; Weiss TS; Schwab M; Zanger UM
BMC Cancer; 2015 Jun; 15():488. PubMed ID: 26122096
[TBL] [Abstract][Full Text] [Related]
8. Direct transcriptional regulation of human hepatic cytochrome P450 3A4 (CYP3A4) by peroxisome proliferator-activated receptor alpha (PPARα).
Thomas M; Burk O; Klumpp B; Kandel BA; Damm G; Weiss TS; Klein K; Schwab M; Zanger UM
Mol Pharmacol; 2013 Mar; 83(3):709-18. PubMed ID: 23295386
[TBL] [Abstract][Full Text] [Related]
9. Feedback looping between ChREBP and PPARα in the regulation of lipid metabolism in brown adipose tissues.
Iizuka K; Wu W; Horikawa Y; Saito M; Takeda J
Endocr J; 2013; 60(10):1145-53. PubMed ID: 23831548
[TBL] [Abstract][Full Text] [Related]
10. Paraoxonase 2 Facilitates Pancreatic Cancer Growth and Metastasis by Stimulating GLUT1-Mediated Glucose Transport.
Nagarajan A; Dogra SK; Sun L; Gandotra N; Ho T; Cai G; Cline G; Kumar P; Cowles RA; Wajapeyee N
Mol Cell; 2017 Aug; 67(4):685-701.e6. PubMed ID: 28803777
[TBL] [Abstract][Full Text] [Related]
11. A proteome analysis of livers from obese (ob/ob) mice treated with the peroxisome proliferator WY14,643.
Edvardsson U; Alexandersson M; Brockenhuus von Löwenhielm H; Nyström AC; Ljung B; Nilsson F; Dahllöf B
Electrophoresis; 1999; 20(4-5):935-42. PubMed ID: 10344269
[TBL] [Abstract][Full Text] [Related]
12. D-Allose Inhibits Cancer Cell Growth by Reducing GLUT1 Expression.
Noguchi C; Kamitori K; Hossain A; Hoshikawa H; Katagi A; Dong Y; Sui L; Tokuda M; Yamaguchi F
Tohoku J Exp Med; 2016 Feb; 238(2):131-41. PubMed ID: 26829886
[TBL] [Abstract][Full Text] [Related]
13. Aspirin inhibits the proliferation of hepatoma cells through controlling GLUT1-mediated glucose metabolism.
Liu YX; Feng JY; Sun MM; Liu BW; Yang G; Bu YN; Zhao M; Wang TJ; Zhang WY; Yuan HF; Zhang XD
Acta Pharmacol Sin; 2019 Jan; 40(1):122-132. PubMed ID: 29925918
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor alpha is involved in the regulation of lipid metabolism by ginseng.
Yoon M; Lee H; Jeong S; Kim JJ; Nicol CJ; Nam KW; Kim M; Cho BG; Oh GT
Br J Pharmacol; 2003 Apr; 138(7):1295-302. PubMed ID: 12711630
[TBL] [Abstract][Full Text] [Related]
15. A nonthiazolidinedione peroxisome proliferator-activated receptor α/γ dual agonist CG301360 alleviates insulin resistance and lipid dysregulation in db/db mice.
Jeong HW; Lee JW; Kim WS; Choe SS; Shin HJ; Lee GY; Shin D; Lee JH; Choi EB; Lee HK; Yon GH; Cho B; Kim HR; Choi SH; Chung YS; Park SB; Chung H; Ro S; Kim JB
Mol Pharmacol; 2010 Nov; 78(5):877-85. PubMed ID: 20724462
[TBL] [Abstract][Full Text] [Related]
16. FOXM1 promotes reprogramming of glucose metabolism in epithelial ovarian cancer cells via activation of GLUT1 and HK2 transcription.
Wang Y; Yun Y; Wu B; Wen L; Wen M; Yang H; Zhao L; Liu W; Huang S; Wen N; Li Y
Oncotarget; 2016 Jul; 7(30):47985-47997. PubMed ID: 27351131
[TBL] [Abstract][Full Text] [Related]
17. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor alpha and gamma ligands differentially affect smooth muscle cell proliferation and migration.
Zahradka P; Wright B; Fuerst M; Yurkova N; Molnar K; Taylor CG
J Pharmacol Exp Ther; 2006 May; 317(2):651-9. PubMed ID: 16407462
[TBL] [Abstract][Full Text] [Related]
19. PPARδ promotes tumor progression via activation of Glut1 and SLC1-A5 transcription.
Zhang W; Xu Y; Xu Q; Shi H; Shi J; Hou Y
Carcinogenesis; 2017 Jul; 38(7):748-755. PubMed ID: 28419191
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome-proliferator-activated receptor alpha agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1.
Grau R; Punzón C; Fresno M; Iñiguez MA
Biochem J; 2006 Apr; 395(1):81-8. PubMed ID: 16343055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
